Exchange: NASDAQ·Updated 07:39 PM EDT
ILMN logo

ILMNIllumina Inc

$161.93
$2.84
(1.78%)
Today
Closed $161.93
$0.12
(0.07%)
After Hours
EarningsJul 30
Mkt Cap$24.5B
Vol3.1M
News
all
press releases
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
More News
News Placeholder
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution PR Newswire SAN DIEGO, June 8, 2026 StrataMap Spatial gives researchers...
PR Newswire
News Placeholder
Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?
Recursion Pharmaceuticals (RXRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge?
Illumina shares surge 98.7% in a year as NovaSeq X adoption accelerates, clinical sequencing demand grows, and the company tops Q1 2026 guidance.
Zacks
News Placeholder
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.
Zacks
News Placeholder
Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?
QIAGEN cuts its 2026 growth outlook after a Q1 miss, but margins, cash flow and a debt-free balance sheet could steady the narrative.
Zacks
News Placeholder
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research PR Newswire SAN DIEGO, May 28, 2026 Automating library prep reduces hands-on time for customers using Pillar...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.